Falls Church, VA · Founded 2021 · Privately Held (backing)
Developer an intestinal microsomal triglyceride transfer protein inhibitor designed to treat the metabolic side effects of antipsychotic drugs. Response Pharmaceuticals is based in Falls Church, VA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $16.9 million across 2 recorded rounds; the latest was a $3.9 million debt round in Jun 2024.
PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$16.9M
Last round
Debt
Jun 2024
Cap table — not yet on record
Response Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Response Pharmaceuticals with a free account
·Watch Response Pharmaceuticals: the Monday email on marks, rounds and moves
Where does Response Pharmaceuticals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Response Pharmaceuticals's 2 recorded funding rounds.
